NCT02748837View on ClinicalTrials.gov

A Study of ERY974 in Patient With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

August 31, 2019

Study Completion Date

August 31, 2019

Conditions
Solid Tumors
Interventions
DRUG

ERY974

Trial Locations (10)

Unknown

Washington D.C.

Tampa

Boston

Detroit

New York

Durham

Providence

Paris

Villejuif

Groningen

Sponsors
All Listed Sponsors
lead

Chugai Pharmaceutical

INDUSTRY